CNS and Neurological Disorders - Drug Targets : Impact Factor & More
eISSN: 1996-3181pISSN: 1871-5273
Share this on:
Key Metrics
CiteScore 
6.4
Impact Factor
< 5
SNIP
0.64
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
CNS and Neurological Disorders - Drug Targets Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CNS and Neurological Disorders - Drug Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CNS and Neurological Disorders - Drug Targets
Mechanistic Insights into Terpenoid-Based Therapy for Parkinson's Disease.
- 9 May 2026
- CNS & neurological disorders drug targets
Synthetic Imidazole Derivatives as Multitarget Agents in Depression: Insights into Mechanism and Therapeutic Promise.
- 8 May 2026
- CNS & neurological disorders drug targets
Challenges in Brain Drug Delivery for Neurodegenerative Disorders and Recent Trends: A Review.
- 8 May 2026
- CNS & neurological disorders drug targets
Brigatinib in ALK-fused, Low-grade Pediatric Angiocentric Glioma with Multiple Extracranial Metastases: A Case Report.
- 8 May 2026
- CNS & neurological disorders drug targets
Future of Preclinical Depression Research: A Perspective of Behavioral Models with Validity and Translational Potential Description.
- 8 May 2026
- CNS & neurological disorders drug targets
Tirofiban-Nimodipine Combination Therapy for Early Neurological Deterioration in Small Artery Occlusion Stroke: A Retrospective Cohort Study.
- 8 May 2026
- CNS & neurological disorders drug targets
Mechanistic Insights into Terpenoid-Based Therapy for Parkinson's Disease.
- 9 May 2026
- CNS & neurological disorders drug targets
Synthetic Imidazole Derivatives as Multitarget Agents in Depression: Insights into Mechanism and Therapeutic Promise.
- 8 May 2026
- CNS & neurological disorders drug targets
Challenges in Brain Drug Delivery for Neurodegenerative Disorders and Recent Trends: A Review.
- 8 May 2026
- CNS & neurological disorders drug targets
Brigatinib in ALK-fused, Low-grade Pediatric Angiocentric Glioma with Multiple Extracranial Metastases: A Case Report.
- 8 May 2026
- CNS & neurological disorders drug targets
Future of Preclinical Depression Research: A Perspective of Behavioral Models with Validity and Translational Potential Description.
- 8 May 2026
- CNS & neurological disorders drug targets
Tirofiban-Nimodipine Combination Therapy for Early Neurological Deterioration in Small Artery Occlusion Stroke: A Retrospective Cohort Study.
- 8 May 2026
- CNS & neurological disorders drug targets
FAQs on CNS and Neurological Disorders - Drug Targets
How long has CNS and Neurological Disorders - Drug Targets been actively publishing? 
What is the publishing frequency of CNS and Neurological Disorders - Drug Targets?
How many articles did CNS and Neurological Disorders - Drug Targets publish last year?
What is the eISSN & pISSN for CNS and Neurological Disorders - Drug Targets?
What is Citescore for CNS and Neurological Disorders - Drug Targets?
What is SNIP score for CNS and Neurological Disorders - Drug Targets?
Who is the publisher of CNS and Neurological Disorders - Drug Targets?
